Private Equity
A compilation of personnel moves from the previous month at various firms, including OpenView and Defy, among others.
2 min read · 16 May 2019
DGNL Ventures has raised over $14.9 million for its new fund, according to an SEC filing. DGNL Ventures is an early-stage venture firm focused on emerging brands.
1 min read · 16 May 2019
Miraki Innovation has launched a $175 million medical technology breakthrough fund. This will be the third fund started and managed by Christopher Velis, founder of Miraki Innovation and co-founder of Auris Health.
2 min read · 16 May 2019
Tools4Patient SA, a Belgian developer of tools to optimize and accelerate drug development programs, has raised $4.5 million in Series B financing. The investors included Innovation Fund, Sambrinvestm, Jean-Pierre Delwart, former CEO of Eurogentec and Jean Stephenne, former president of GlaxoSmithKline Biologicals.
1 min read · 16 May 2019
Tools4Patient SA, a Belgian developer of tools to optimize and accelerate drug development programs, has raised $4.5 million in Series B financing. The investors included Innovation Fund, Sambrinvestm, Jean-Pierre Delwart, former CEO of Eurogentec and Jean Stephenne, former president of GlaxoSmithKline Biologicals.
1 min read · 16 May 2019
New York City-based Prevail Therapeutics Inc, a gene therapy company, has promoted Dr. Yong Dai to chief technology officer. Also, the company has named Tim Adams to its board of directors as audit committee chair while Dr. Francois Nader, a member of the board, will expand his role as non-executive chairman. Prevail's backers include OrbiMed, Pontifax Fund, RA Capital Management, EcoR1 Capital, Omega Funds, BVF Partners LP, Boxer Capital LLC, Adage Capital Management LP and Alexandria Venture Investments.
4 min read · 16 May 2019
New York City-based Prevail Therapeutics Inc, a gene therapy company, has promoted Dr. Yong Dai to chief technology officer. Also, the company has named Tim Adams to its board of directors as audit committee chair while Dr. Francois Nader, a member of the board, will expand his role as non-executive chairman. Prevail's backers include OrbiMed, Pontifax Fund, RA Capital Management, EcoR1 Capital, Omega Funds, BVF Partners LP, Boxer Capital LLC, Adage Capital Management LP and Alexandria Venture Investments.
4 min read · 16 May 2019
Accel has raised $575 million for its sixth fund that will invest in early-stage companies in Europe and Israel. Headquartered in Palo Alto, California, Accel has offices in San Francisco, London, India and China.
2 min read · 16 May 2019
1 min read · 16 May 2019
1 min read · 15 May 2019
